Conservative Therapies in the Treatment of Temporomandibular Disorders
NCT: NCT05989217 · COMPLETED
Brief Summary
The present study was designed to evaluate different conservative therapies in patients with temporomandibular disorders. A total of 160 patients will be selected after the diagnosis of TMD according to the Diagnostic Criteria for Temporomandibular Disorder (DC/TMD), axis I. Patients will be randomly divided into five groups: OD group (n=32): treated with an occlusal device; LLLT group (n=32): treated with infrared low-level laser; ODL group (n=32): treated with OD + LLLT; LAT group (n=32): treated with laser acupuncture and ODLAT group (n=32): treated with both OD and LAT. Patients undergoing therapy with a stabilizing plate (made using the simplified technique) will be instructed to use the device every night while sleeping for four weeks. In both the LLLT and LAT groups, the protocol involved five applications: one at baseline, followed by four subsequent weekly sessions. The intensity of pain will be classified using the Visual Analog Scale (VAS). Mandible function will be assessed by maximum unassisted mouth opening. The impact of therapies on oral health will also be evaluated using the Oral Health Impact Profile (OHIP-14) instrument in a simplified form.
Frequently Asked Questions
What is Conservative Therapies in the Treatment of Temporomandibular Disorders?
Conservative Therapies in the Treatment of Temporomandibular Disorders is a clinical trial registered under NCT05989217. Current status: COMPLETED.
What is the status of NCT05989217?
The current status of NCT05989217 (Conservative Therapies in the Treatment of Temporomandibular Disorders) is: COMPLETED.
When did Conservative Therapies in the Treatment of Temporomandibular Disorders start?
Conservative Therapies in the Treatment of Temporomandibular Disorders started on 2023-03-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.